Secondary Logo

Journal Logo

Institutional members access full text with Ovid®


Karacorlu, Murat MD, MSc, FEBO; Sayman Muslubas, Isil MD, FEBO; Hocaoglu, Mumin MD, FEBO; Arf, Serra MD; Ersoz, Mehmet Giray MD

doi: 10.1097/IAE.0000000000001390
Original Study

Purpose: To evaluate the long-term results of total retinectomy in patients with rhegmatogenous retinal detachment and severe proliferative vitreoretinopathy.

Methods: Seven eyes of 7 patients had pars plana vitrectomy, with or without pars plana lensectomy, and total retinectomy, with or without silicone oil tamponade, for the management of rhegmatogenous retinal detachment and proliferative vitreoretinopathy (Grade D1–3) after previous complex vitreoretinal surgery procedures. Visual acuity, intraocular pressure, details of previous operations, and development of complications were evaluated retrospectively.

Results: Five eyes had a history of penetrating eye trauma, one had persistent fetal vasculature, and one had Coats disease. Patients were all male, with a mean age of 15 ± 11 years (range, 2–31). The mean follow-up was 49.7 ± 50.2 months (range, 12–132). In 3 eyes (42%), enucleation and evisceration were avoided over a mean 100 ± 30.2 month follow-up. All 7 eyes had corneal opacity and band keratopathy after a mean 4.4 ± 3.2 months. Four eyes had phthisis bulbi after a mean 7 ± 4.2 months. No patients developed rubeosis iridis related to the total retinectomy.

Conclusion: Total retinectomy may be a last option to preserve the eyeball in cases with massive fibrosis and rhegmatogenous retinal detachment, despite previous complex surgical treatments.

Total retinectomy may be a last option to prevent rubeosis iridis, persistent hypotony, and phthisis bulbi in cases with massive fibrosis and rhegmatogenous retinal detachment, despite previous complex surgical treatments.

Istanbul Retina Institute, Istanbul, Turkey.

Reprint requests: Murat Karacorlu, MD, MSc, FEBO, Istanbul Retina Institute, Hakkı Yeten Cad. Unimed Center No: 19/7, Fulya-Şişli, Istanbul 34349, Turkey; e-mail:

None of the authors has any financial/conflicting interests to disclose.

The authors had full access to all the data in the study and take full responsibility for the integrity and the accuracy of the data as well as the decision to submit for publication. All authors approved the manuscript and its submission.

© 2017 by Ophthalmic Communications Society, Inc.